Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 15, 2023
Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer
Sushmita Gordhandas, William A Zammarrelli, Eric V Rios-Doria, et al.
Gynecologic Oncology
|
May 16, 2021
Sentinel lymph node biopsy in patients with endometrial cancer and an indocyanine green or iodinated contrast reaction - A proposed management algorithm
William A Zammarrelli, Anoushka M Afonso, Vance Broach, et al.
Gynecologic Oncology
|
December 24, 2022
Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study
Sarah Ehmann, Kelly Shay, Qin Zhou, et al.
Gynecologic Oncology
|
September 25, 2023
Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
William A Zammarrelli, Weining Ma, Kevin Espino, et al.
Gynecologic Oncology
|
March 2, 2022
Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcoma
William A Zammarrelli, Michelle Greenman, Eric Rios-Doria, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer
Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, et al.
The Journal of Clinical Investigation
|
June 20, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer
Nicolás Gómez-Banoy, Eduardo J Ortiz, Caroline S Jiang, et al.
JCO Precision Oncology
|
October 14, 2022
Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular Classification
William A Zammarrelli, Sarah H Kim, Arnaud Da Cruz Paula, et al.
Gynecologic Oncology
|
March 13, 2025
The genomic landscape of distant metastatic endometrial cancer
William A Zammarrelli, Subhiksha Nandakumar, Elizabeth Kertowidjojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer
Angela K Green, Qin Zhou, Alexia Iasonos, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 15, 2023
Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer
Sushmita Gordhandas, William A Zammarrelli, Eric V Rios-Doria, et al.
Gynecologic Oncology
|
May 16, 2021
Sentinel lymph node biopsy in patients with endometrial cancer and an indocyanine green or iodinated contrast reaction - A proposed management algorithm
William A Zammarrelli, Anoushka M Afonso, Vance Broach, et al.
Gynecologic Oncology
|
December 24, 2022
Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study
Sarah Ehmann, Kelly Shay, Qin Zhou, et al.
Gynecologic Oncology
|
September 25, 2023
Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
William A Zammarrelli, Weining Ma, Kevin Espino, et al.
Gynecologic Oncology
|
March 2, 2022
Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcoma
William A Zammarrelli, Michelle Greenman, Eric Rios-Doria, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer
Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang, et al.
The Journal of Clinical Investigation
|
June 20, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer
Nicolás Gómez-Banoy, Eduardo J Ortiz, Caroline S Jiang, et al.
JCO Precision Oncology
|
October 14, 2022
Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular Classification
William A Zammarrelli, Sarah H Kim, Arnaud Da Cruz Paula, et al.
Gynecologic Oncology
|
March 13, 2025
The genomic landscape of distant metastatic endometrial cancer
William A Zammarrelli, Subhiksha Nandakumar, Elizabeth Kertowidjojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer
Angela K Green, Qin Zhou, Alexia Iasonos, et al.
Page
of 2